Gamida Cell P/E 2024

Gamida Cell P/E

-0.03

Gamida Cell Dividend yield

Ticker

GMDA

ISIN

IL0011552663

WKN

A2N7XM

As of Mar 29, 2024, Gamida Cell's P/E ratio was -0.03, a -97.92% change from the -1.44 P/E ratio recorded in the previous year.

The Gamida Cell P/E history

Gamida Cell Aktienanalyse

What does Gamida Cell do?

The company Gamida Cell Ltd was founded in 1998 in Jerusalem, Israel and is involved in the development and manufacture of cell therapy products for various diseases. The company has had an exciting history since its inception, including a number of successes and milestones. Gamida Cell's business model is based on the production of cell therapy products for patients suffering from severe diseases. These include blood diseases such as leukemia, lymphoma, or sickle cell anemia. The company uses a unique technology platform called "NiCord," which allows for the extraction and expansion of cells from umbilical cord blood to provide a larger number of cells for transplantation. This platform offers a way to overcome some of the limitations and challenges associated with the use of bone marrow or stem cell donors. Gamida Cell has made significant progress in the development of cell therapy products in recent years. The company is currently working on the development of therapies for various indications such as blood diseases, solid tumors, and autoimmune diseases. Another goal of Gamida Cell is to use its technology platform for the development of drugs for other indications. The company has various divisions in which it operates. The primary division is research and development of cell therapies. However, the company also has a manufacturing facility for the production of its products and a clinical studies department responsible for conducting studies and tests of therapeutics. Gamida Cell collaborates closely with research institutions and other companies in the biotechnology industry to further develop its technology platform and advance the progress of cell therapies overall. Gamida Cell currently offers a range of products, starting with its flagship product "NiCord." NiCord is a cell therapy made from umbilical cord blood cells and can be used for transplantation in patients with blood diseases such as leukemia or lymphoma. The company is also working on the development of additional products, including a cell therapy for solid tumors and a treatment for autoimmune diseases. In recent years, Gamida Cell has received several awards and recognitions. The company has attracted several leading scientists and researchers who collaborate closely with Gamida Cell to further develop the company's technology platform and create new therapies. At the same time, Gamida Cell has also carried out several capital increases to advance research and product development. Overall, Gamida Cell has an excellent reputation in the biotech industry. The company has shown that it can play a leading role in the development of cell therapies that can improve the lives of patients with severe diseases. With the growing demand for new treatment options and the rapid progress in the field of biotech, Gamida Cell is well positioned to continue expanding and developing new therapies that have the potential to change the lives of millions of people worldwide. Gamida Cell ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Gamida Cell's P/E Ratio

The Price to Earnings (P/E) Ratio of Gamida Cell is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Gamida Cell's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Gamida Cell is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Gamida Cell’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Gamida Cell Stock

What is the price-to-earnings ratio of Gamida Cell?

The price-earnings ratio of Gamida Cell is currently -0.03.

How has the price-earnings ratio of Gamida Cell changed compared to last year?

The price-to-earnings ratio of Gamida Cell has increased by -97.92% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Gamida Cell high compared to other companies?

Yes, the price-to-earnings ratio of Gamida Cell is high compared to other companies.

How does an increase in the price-earnings ratio of Gamida Cell affect the company?

An increase in the price-earnings ratio of Gamida Cell would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Gamida Cell affect the company?

A decrease in the price-earnings ratio of Gamida Cell would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Gamida Cell?

Some factors that influence the price-earnings ratio of Gamida Cell are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Gamida Cell pay?

Over the past 12 months, Gamida Cell paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Gamida Cell is expected to pay a dividend of 0 USD.

What is the dividend yield of Gamida Cell?

The current dividend yield of Gamida Cell is .

When does Gamida Cell pay dividends?

Gamida Cell pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gamida Cell?

Gamida Cell paid dividends every year for the past 0 years.

What is the dividend of Gamida Cell?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Gamida Cell located?

Gamida Cell is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gamida Cell kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gamida Cell from 3/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/29/2024.

When did Gamida Cell pay the last dividend?

The last dividend was paid out on 3/29/2024.

What was the dividend of Gamida Cell in the year 2023?

In the year 2023, Gamida Cell distributed 0 USD as dividends.

In which currency does Gamida Cell pay out the dividend?

The dividends of Gamida Cell are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Gamida Cell

Our stock analysis for Gamida Cell Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gamida Cell Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.